Literature DB >> 17712725

Immune-mediated activation of the endocannabinoid system in visceral adipose tissue in obesity.

K Kempf1, J Hector, T Strate, B Schwarzloh, B Rose, C Herder, S Martin, P Algenstaedt.   

Abstract

The aim of the study was to investigate if the endocannabinoid system (ECS) is activated in visceral adipose tissue and if adipose tissue inflammation affects the ECS activation state. Therefore, expression of fatty acid amide hydrolase (FAAH), cannabinoid receptor 1 (Cb1), adiponectin, and tumor necrosis factor (TNF)-alpha was compared in visceral adipose tissue from 10 normal-weight (BMI 24.4+/-1.1 kg/m2) and 11 obese subjects (BMI 37.6+/-13.6 kg/m2) using quantitative RT-PCR, and gene expression changes were analyzed after in vitro stimulation of visceral adipose tissue with TNF-alpha. The data demonstrate that the ECS is activated in obese visceral adipose tissue as shown by decreased FAAH, Cb1, and adiponectin expression. Obesity-related ECS activation is accompanied by elevated expression of the pro-inflammatory cytokine TNF-alpha, which in turn stimulates ECS activation in vitro. Our data show a strong association between adipose tissue inflammation and ECS activation in obesity, and indicate that a pro-inflammatory state may directly activate the ECS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17712725     DOI: 10.1055/s-2007-984459

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  10 in total

1.  Anti-inflammatory cannabinoids in diet: Towards a better understanding of CB(2) receptor action?

Authors:  Jürg Gertsch
Journal:  Commun Integr Biol       Date:  2008

Review 2.  The endocannabinoid system in obesity and type 2 diabetes.

Authors:  V Di Marzo
Journal:  Diabetologia       Date:  2008-06-18       Impact factor: 10.122

3.  CB1 antagonism exerts specific molecular effects on visceral and subcutaneous fat and reverses liver steatosis in diet-induced obese mice.

Authors:  Tony Jourdan; Louiza Djaouti; Laurent Demizieux; Joseph Gresti; Bruno Vergès; Pascal Degrace
Journal:  Diabetes       Date:  2010-01-28       Impact factor: 9.461

4.  Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients.

Authors:  Giovanni Annuzzi; Fabiana Piscitelli; Lucrezia Di Marino; Lidia Patti; Rosalba Giacco; Giuseppina Costabile; Lutgarda Bozzetto; Gabriele Riccardi; Roberta Verde; Stefania Petrosino; Angela A Rivellese; Vincenzo Di Marzo
Journal:  Lipids Health Dis       Date:  2010-04-28       Impact factor: 3.876

Review 5.  Endocannabinoids and the control of energy homeostasis.

Authors:  George Kunos; Douglas Osei-Hyiaman; Jie Liu; Gregorz Godlewski; Sándor Bátkai
Journal:  J Biol Chem       Date:  2008-08-11       Impact factor: 5.157

Review 6.  The dynamic nature of type 1 cannabinoid receptor (CB(1) ) gene transcription.

Authors:  R B Laprairie; M E M Kelly; E M Denovan-Wright
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 8.739

7.  Deletion of G-protein-coupled receptor 55 promotes obesity by reducing physical activity.

Authors:  A Meadows; J H Lee; C-S Wu; Q Wei; G Pradhan; M Yafi; H-C Lu; Y Sun
Journal:  Int J Obes (Lond)       Date:  2015-10-08       Impact factor: 5.095

8.  Adipose tissue endocannabinoid system gene expression: depot differences and effects of diet and exercise.

Authors:  Tongjian You; Beth L Disanzo; Xuewen Wang; Rongze Yang; Dawei Gong
Journal:  Lipids Health Dis       Date:  2011-10-28       Impact factor: 3.876

Review 9.  Endocannabinoids in immune regulation and immunopathologies.

Authors:  Oindrila Rahaman; Dipyaman Ganguly
Journal:  Immunology       Date:  2021-07-08       Impact factor: 7.215

10.  Developmental programming of somatic growth, behavior and endocannabinoid metabolism by variation of early postnatal nutrition in a cross-fostering mouse model.

Authors:  Felix Schreiner; Merle Ackermann; Michael Michalik; Eva Hucklenbruch-Rother; Andras Bilkei-Gorzo; Ildiko Racz; Laura Bindila; Beat Lutz; Jörg Dötsch; Andreas Zimmer; Joachim Woelfle
Journal:  PLoS One       Date:  2017-08-31       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.